Publication

Article

CURE

Fall 2009
Volume8
Issue 3

CYP2D6 Inhibitors

>

Strong CYP2D6 Inhibitors* Paxil (paroxetine)

>

Prozac (fluoxetine)

>

Wellbutrin (bupropion)

>

Moderate CYP2D6 Inhibitors Cymbalta (duloxetine)

>

Zoloft (sertraline)

>

Weak CYP2D6 Inhibitors Celexa (citalopram)

>

Effexor (venlafaxine)

>

Lexapro (escitalopram)

Source: Abbreviated listing from Handbook of Essential Psychopharmacology, second edition, 2005

*To be avoided with tamoxifen

Articles in this issue
Web Exclusive: Quiz: Do You Know the Recommended Screening Guidelines?
Web Exclusive: When is Multidisciplinary Care Really Needed?
The Internal Flame
Message from the Editor
Letters from Our Readers
Overheated
I Laughed
Kidney Cancer & Lung Cancer
Cancer Screening
Life Preserver?
Teen Tribulations
Breast Cancer Around the World
Deconstructing Grief
Big Tobacco, Meet the FDA
A Lion, An Angel, and a Pioneer
Related Content
Image of a woman with her hand hovering over a laptop keyboard.
December 18th 2024

How to Get the Most from Patient Portals During a Cancer Journey

Alex Biese
An expert advises a few things to keep in mind when patients with cancer are navigating these platforms.
Image of question marks.
December 16th 2024

Delivering Answers to Pressing Questions About Cancer

Mike Hennessy Jr.
At CURE, we remain steadfastly dedicated to providing our readers with answers about cancer research.
Image of a patient talking to a nurse.
December 15th 2024

An Extraordinary Healer Inside and Out

Colleen Bruen, RN, BSN, BMTCN
Oncology nurse Denise always makes it a point to focus on the “big picture” for all of her patients with cancer.
Image of a man wearing a gray suit.
December 6th 2024

The ABCs of ADCs in Breast Cancer

Debu Tripathy, M.D.
Since 2000, antibody-drug conjugates have been approved by the Food and Drug Administration for various cancer types, such as breast cancer.
Image of a woman with a dark medium bob and bangs, wearing a white and orange shawl.
December 5th 2024

Finding Hope With Antibody-Drug Conjugates in Managing Breast Cancer

Alex Biese
With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast cancer?
Image of hands in the shape of a heart.
December 1st 2024

Easing Out Fear and Welcoming in Hope

Wendy Austin
Kim Moeller, a compassionate oncology nurse, empowers patients by alleviating fear and fostering hope through empathetic listening and personalized care.